Argentina
Colombia
Malaysia
Mexico
Other LatAm Countries
English
-
-
Dengue in the Midst of COVID-19 Pandemic
ADVA14 minutes -
Dengue disease awareness
ISID39 minutes -
What is the diagnosis? - Challenging Pediatric ID Cases in Dengue Endemic Regions
WSPID59 minutes -
Emerging Issues in Dengue Control
Takeda -
Dengue Infections in Travelers
Takeda -
Public Health Considerations for Dengue
Takeda -
Experience of a tertiary hospital in Singapore managing a dual outbreak of COVID and dengue
Takeda2 minutes -
Adverse Event Management after Dengue Vaccination
Takeda7 minutes -
Case report: Acute vision loss in a young returning traveler with dengue fever
Takeda2 minutes -
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia
Takeda2 minutes -
First autochthonous dengue outbreak in Italy, August 2020
Takeda2 minutes -
Dengue is the most common non-malarial febrile illness in Southern Asia and Southeastern Asia
Takeda2 minutes -
When fever is not malaria in Latin America
Takeda2 minutes -
Surveillance and Reporting
Takeda5 minutes -
Antibody Levels over Time
Takeda2 minutes -
Laboratory diagnostic tests
Takeda -
Case presentations in severe dengue: contemporary approaches to clinical management
Medscape45 minutes -
Differential diagnosis
Takeda1 minutes -
Management of cases
Takeda1 minutes -
Dengue disease states
Takeda4 minutes -
Burden of Dengue
Takeda38 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Managing the severely ill dengue patients – Adult and Paediatric Intensivists
ADVA92 minutes -
Clinical diagnosis and management of dengue
PAHO -
Dengue Clinical Case Management
CDC -
The global trends and regional differences in incidence of dengue infection from 1990 to 2019: An analysis from the Global Burden of Disease Study 2019
Takeda2 minutes -
Emerging Issues in Pediatric Dengue
WSPID50 minutes -
Antibody-dependent enhancement of severe dengue disease in humans
Takeda2 minutes -
Dengue: diagnosis and treatment updates
ISID62 minutes -
Resources for patient support
Takeda3 minutes -
Causes of fever in returning travelers: A European multicenter prospective cohort study
Takeda2 minutes -
Dengue diagnosis: unique challenges in a time of a pandemic
Medscape15 minutes -
Dengue virus infections among European travellers, 2015 to 2019
Takeda2 minutes -
Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes
Takeda2 minutes -
Dengue: a global threat
WSPID38 minutes -
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study
Takeda2 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
This website is intended for informational purposes only and is not a substitute for healthcare professional’s clinical knowledge or professional judgment.
© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023